 Basiliximab and daclizumab inhibit IL-2 on activated T cells and thereby help preventing acute rejection of kidney transplants.Omalizumab inhibits human immunoglobulin E (IgE) and is useful in moderate-to-severe allergic asthma.Alzheimer's disease (AD) is a multi-faceted, age-dependent, progressive neurodegenerative disorder, and is a major cause of dementia.